Drug Type Synthetic peptide |
Synonyms NIP 022, NIP022, ONO-7746 + [2] |
Target |
Mechanism TPO receptor agonists(Thrombopoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | US | 01 May 2011 | |
Neoplasms | Phase 1 | RU | 01 May 2011 | |
Neoplasms | Phase 1 | KR | 01 May 2011 | |
Thrombocytopenia | Phase 1 | US | 01 May 2011 | |
Thrombocytopenia | Phase 1 | RU | 01 May 2011 | |
Thrombocytopenia | Phase 1 | KR | 01 May 2011 |